Jörg Fischer Selected Research

Schnitzler Syndrome

1/2020	Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome.
4/2017	Efficacy and safety of canakinumab in Schnitzler syndrome: A multicenter randomized placebo-controlled study.
7/2012	Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jörg Fischer Research Topics

Disease

16	Hypersensitivity (Allergy) 10/2022 - 09/2008
8	red meat allergy 01/2022 - 01/2016
7	Anaphylaxis (Anaphylactic Shock) 01/2022 - 03/2011
3	Schnitzler Syndrome 01/2020 - 07/2012
3	Bites and Stings (Sting) 12/2016 - 09/2008
2	COVID-19 10/2022 - 01/2022
1	Allergic Rhinitis 01/2020
1	Tick Bites 01/2019
1	Inflammation (Inflammations) 04/2017
1	Rare Diseases (Rare Disease) 04/2017
1	Immediate Hypersensitivity 01/2016
1	Food Hypersensitivity (Food Allergy) 01/2016
1	Asthma (Bronchial Asthma) 01/2014
1	Rheumatoid Arthritis 12/2012
1	Mastocytosis 03/2011
1	Allergic Contact Dermatitis 05/2010
1	Melanoma (Melanoma, Malignant) 01/2004
1	Lymphatic Metastasis 11/2002
1	Carcinogenesis 11/2002
1	Breast Neoplasms (Breast Cancer) 11/2002
1	Choroid Diseases 04/2002
1	Macular Degeneration (Age-Related Maculopathy) 04/2002
1	Retinal Diseases 04/2002
1	Choroidal Neovascularization 04/2002

Drug/Important Bio-Agent (IBA)

9	Immunoglobulin E (IgE)IBA 01/2022 - 01/2016
6	CarbohydratesIBA 01/2022 - 01/2019
6	AllergensIBA 01/2020 - 12/2012
4	AntibodiesIBA 01/2020 - 01/2019
3	Wasp Venoms (Venom, Wasp)IBA 08/2013 - 09/2008
2	COVID-19 VaccinesIBA 10/2022 - 01/2022
2	VaccinesIBA 10/2022 - 01/2022
2	canakinumab FDA Link 01/2020 - 04/2017
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2016
2	Bee Venoms (Bee Venom)IBA 12/2016 - 12/2012
2	Messenger RNA (mRNA)IBA 01/2004 - 11/2002
1	EpitopesIBA 01/2022
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2022
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022
1	mRNA VaccinesIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	GlycolipidsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Arthropod VenomsIBA 01/2020
1	AntigensIBA 01/2020
1	VenomsIBA 01/2020
1	OligosaccharidesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	C-Reactive ProteinIBA 04/2017
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 04/2017
1	Amyloid (Amyloid Fibrils)IBA 04/2017
1	SugarsIBA 01/2016
1	DisaccharidesIBA 01/2016
1	N,N- dimethylcarbamoyl- 4- (4- guanidinobenzyloxy)phenyl acetate methane sulfateIBA 01/2014
1	4'-N,N-dimethylamino-4-aminoazobenzeneIBA 01/2014
1	GelatinIBA 05/2013
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2012
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2012
1	Interleukin-1 (Interleukin 1)IBA 07/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2011
1	Hair DyesIBA 05/2010
1	Tuberculin (PPD)IBA 05/2010
1	4-phenylenediamine (p-phenylenediamine)FDA Link 05/2010
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2004
1	Chondroitin Sulfate ProteoglycansIBA 01/2004
1	Monoclonal AntibodiesIBA 01/2004
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 11/2002
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 04/2002
1	Retinaldehyde (Retinal)IBA 04/2002

Therapy/Procedure

2	Immunotherapy 12/2016 - 12/2012
2	Therapeutics 01/2014 - 07/2012
1	Injections 01/2022
1	Critical Care (Surgical Intensive Care) 01/2014
1	Tattooing 05/2010
1	Lasers (Laser) 04/2002